AmerisourceBergen Corporation (Holding Co) (ABC) : Fridays money flow points at investors jumping to buy the stock on the weakness of price. $3.05 million worth of transactions were on upticks, whereas, the downticks accounted for $1.74 million worth of transactions. The net money flow was a positive $1.3 million and the uptick to downtick ratio was 1.75. The net money flow into the stock was $1.49 million. The lack of interest in trading on downticks shows that the investors dont want to sell their holdings. The upticks accounted for $1.49 million of the total block trades, indicating continued buying interest on weakness, which bodes well for the future of the stock. AmerisourceBergen Corporation (Holding Co) (ABC) was trading at $85.42, down $0.39 during day. The stock slid -0.45% over the previous days close. For the week, the stock recorded -0.15% over the previous weeks close.
AmerisourceBergen Corporation (Holding Co) (ABC) : Average target price received by AmerisourceBergen Corporation (Holding Co) (ABC) is $85.73 with an expected standard deviation of $7.27. The most aggressive target on the stock is $105, whereas the most downbeat target is $77. 11 financial analysts are currently covering the stock.
AmerisourceBergen Corporation (Holding Co) (NYSE:ABC): stock turned positive on Friday. Though the stock opened at $86.01, the bulls momentum made the stock top out at $86.21 level for the day. The stock recorded a low of $85.1949 and closed the trading day at $85.86, in the green by 0.06%. The total traded volume for the day was 1,331,479. The stock had closed at $85.81 in the previous days trading.
In a related news,The officer (Executive Vice President) of Amerisourcebergen Corp, Danilewitz Dale sold 1,586 shares at $86.8 on March 1, 2016. The Insider selling transaction had a total value worth of $137,665. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. The Company provides pharmacy services to certain specialty drug patients. Additionally, the Company offers healthcare providers and pharmaceutical manufacturers with services, including reimbursement and pharmaceutical consulting services, logistics services, inventory management, pharmacy automation and pharmacy management. The Company has a distribution facility network totaling approximately 30 distribution facilities in the United States.